| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 412.854 | 354.204 | 367.352 | 382.706 | 479.670 | 321.862 | 320.887 | 302.975 | 369.032 | 476.361 |
| Total Income - EUR | 412.854 | 354.204 | 376.129 | 382.710 | 484.944 | 327.130 | 337.272 | 338.379 | 383.341 | 494.752 |
| Total Expenses - EUR | 382.213 | 337.901 | 372.271 | 373.651 | 459.216 | 324.341 | 332.277 | 321.486 | 380.076 | 484.973 |
| Gross Profit/Loss - EUR | 30.641 | 16.302 | 3.858 | 9.059 | 25.728 | 2.789 | 4.995 | 16.893 | 3.265 | 9.778 |
| Net Profit/Loss - EUR | 26.939 | 14.162 | 222 | 5.232 | 20.879 | 790 | 1.860 | 14.031 | 2.474 | 8.238 |
| Employees | 9 | 12 | 13 | 9 | 10 | 10 | 10 | 10 | 10 | 9 |
Check the financial reports for the company - Decasyl Prod Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 277 | 175 | 20.574 | 13.946 | 0 | 35.263 | 25.286 | 23.456 | 19.250 | 553 |
| Current Assets | 19.811 | 33.477 | 29.865 | 5.417 | 37.434 | 45.316 | 36.379 | 26.185 | 33.463 | 20.998 |
| Inventories | 1.744 | 3.130 | 2.971 | 2.415 | 15.489 | 18.113 | 6.473 | 1.798 | 1.069 | 2.235 |
| Receivables | 588 | 791 | 331 | 377 | 9.026 | 9.624 | 314 | 59 | 9.934 | 6.785 |
| Cash | 17.479 | 29.557 | 26.563 | 2.624 | 12.918 | 17.580 | 29.592 | 24.328 | 22.460 | 11.978 |
| Shareholders Funds | 16.030 | 14.215 | 14.197 | 5.502 | 26.274 | 26.566 | 27.837 | 41.954 | 44.301 | 8.286 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.058 | 19.437 | 36.242 | 13.861 | 11.160 | 54.014 | 33.828 | 7.687 | 8.412 | 13.264 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4631 - 4631" | |||||||||
| CAEN Financial Year |
4631
|
|||||||||
Comments - Decasyl Prod Srl